- Home
- CTSO vs PHUN Comparison
CTSO vs PHUN Comparison
Compare CTSO & PHUN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CTSO
- PHUN
- Stock Information
- Founded
- CTSO 1997
- PHUN 2009
- Country
- CTSO United States
- PHUN United States
- Employees
- CTSO N/A
- PHUN N/A
- Industry
- CTSO Medical/Dental Instruments
- PHUN EDP Services
- Sector
- CTSO Health Care
- PHUN Technology
- Exchange
- CTSO Nasdaq
- PHUN Nasdaq
- Market Cap
- CTSO 58.6M
- PHUN 55.9M
- IPO Year
- CTSO N/A
- PHUN N/A
- Fundamental
- Price
- CTSO $0.92
- PHUN $2.96
- Analyst Decision
- CTSO Buy
- PHUN Buy
- Analyst Count
- CTSO 2
- PHUN 2
- Target Price
- CTSO $5.50
- PHUN $7.75
- AVG Volume (30 Days)
- CTSO 78.2K
- PHUN 271.8K
- Earning Date
- CTSO 11-06-2025
- PHUN 11-06-2025
- Dividend Yield
- CTSO N/A
- PHUN N/A
- EPS Growth
- CTSO N/A
- PHUN N/A
- EPS
- CTSO N/A
- PHUN N/A
- Revenue
- CTSO $36,107,520.00
- PHUN $2,400,000.00
- Revenue This Year
- CTSO $11.93
- PHUN N/A
- Revenue Next Year
- CTSO $21.22
- PHUN $72.40
- P/E Ratio
- CTSO N/A
- PHUN N/A
- Revenue Growth
- CTSO 20.18
- PHUN N/A
- 52 Week Low
- CTSO $0.71
- PHUN $2.22
- 52 Week High
- CTSO $1.61
- PHUN $14.60
- Technical
- Relative Strength Index (RSI)
- CTSO 45.35
- PHUN 55.10
- Support Level
- CTSO $0.90
- PHUN $2.80
- Resistance Level
- CTSO $0.96
- PHUN $3.13
- Average True Range (ATR)
- CTSO 0.05
- PHUN 0.17
- MACD
- CTSO -0.00
- PHUN 0.01
- Stochastic Oscillator
- CTSO 16.67
- PHUN 63.85
About CTSO Cytosorbents Corporation
CytoSorbents Corp specializes in treating life-threatening conditions in intensive care and cardiac surgery using proprietary polymer adsorption technology. Its flagship product, CytoSorb, is approved in the EU as an extracorporeal cytokine absorber, aiming to reduce inflammation and prevent multiple organ failure in critical illnesses like sepsis and trauma. Revenue primarily comes from product sales in Germany, with additional income from grant agencies in the United States. The company operates through Direct sales and Distributors/strategic partners in United States, Germany and Other Countries. The company's product consists of Cytosorb, ECOS-300CY, VetResQ, HemoDefend, and DrugSorb-ATR.
About PHUN Phunware Inc.
Phunware Inc is a software company. It is a cloud platform for mobile that provides companies with the products, solutions, and data and services necessary to engage, manage and monetize its mobile application audiences. It derives maximum revenue from United States. The company has two reportable segments: Software subscriptions and services; and Advertising. It derives maximum revenue from Software subscriptions and services.